Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= BRAF mutation
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(7)
+
-
Availability
Open access
(5)
+
-
Under embargo
(1)
+
-
Metadata Only
(1)
+
-
Creation Date
2021
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(5)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(5)
+
-
Scholarly Publications
(2)
+
-
Topic
BRAF mutation
(7)
+
-
advanced melanoma
(2)
+
-
checkpoint inhibitors
(2)
+
-
melanoma
(2)
+
-
targeted therapy
(2)
+
-
Author
Aarts, M.J.B.
(3)
+
-
Blank, C.U.
(3)
+
-
Eertwegh, A.J.M. van den
(3)
+
-
Groot, J.W.B. de
(3)
+
-
Haanen, J.B.A.G.
(3)
+
-
Hospers, G.A.P.
(3)
+
-
Veldt, A.A.M. van der
(3)
+
-
Wouters, M.W.J.M.
(3)
+
-
Berkmortel, F.W.P.J. van den
(2)
+
-
Boers-Sonderen, M.J.
(2)
+
-
Hiel, B. van der
(2)
+
-
Kapiteijn, E.
(2)
+
-
Morreau, H.
(2)
+
-
Piersma, D.
(2)
+
-
Rijn, R.S. van
(2)
+
-
Suijkerbuijk, K.P.M.
(2)
+
-
Tije, A.J. ten
(2)
+
-
Vreugdenhil, G.
(2)
+
-
Wezel, T. van
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
The predictive value of FDG PET/CT for determining progression-free survival in advanced stage III-IV BRAF-mutated melanoma patients treated with targeted therapy
Differentiating benign from malignant thyroid tumors by kinase activity profiling and dabrafenib BRAF V600E targeting
Neoadjuvant cytoreductive treatment with BRAF/MEK inhibition of prior unresectable regionally advanced melanoma to allow complete surgical resection, REDUCTOR
Nationwide outcomes of advanced melanoma according to BRAF(V600) status
Age does matter in adolescents and young adults versus older adults with advanced melanoma
Genomic analysis and clinical management of adolescent cutaneous melanoma
BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer